vision loss tirzepatide and Use of Semaglutide use linked to ophthalmic complications, finds study GLP-1 drugs and vision loss: – Vision loss risks in patients

This makes it particularly valuable for those stuck in cycles of reinfection, poor resilience, or runaway inflammation

Both medications cause some lean mass loss, but the ratio of fat loss to lean mass loss appears to favor tirzepatide based on available body composition data from the SURMOUNT trials

Remember to consult with a qualified healthcare provider to determine if this treatment is right for you and to develop a personalized protocol that addresses your specific needs and goals

& Pugliese, G

Patients typically begin Mounjaro one week after their last Wegovy injection, starting at an appropriate dose as guided by their prescriber